Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Leucine-rich repeat-containing protein 3 is a member of the broad family of proteins characterized by leucine-rich repeat motifs, which are involved in protein-protein interactions. The LRRC3 protein is predicted to function at the plasma membrane, possibly as a signaling molecule or scaffold; it is predominantly expressed in the nervous system, suggesting a role in neural development or cellular connectivity. Its specific biological functions remain unclear, and there is no evidence for involvement in established signaling pathways, disease processes, nor any drug interactions with LRRC3 at present. The gene is annotated as protein coding with several known aliases, and it shares partial homology with other leucine-rich repeat-containing proteins that typically participate in immunity, development, or cellular signaling. Despite its membrane localization and nervous system expression, LRRC3 has not yet been classified as a therapeutic target or shown to have a direct pathogenic or pharmacological role.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Leucine-rich repeat-containing protein 3 (LRRC3).